Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN Podcasts

Back to Item »

GRANDRx—Mission, Goals, and Challenges

Interview with Patrick Terry, Acting CEO of the Grand Therapeutics Foundation, and Christopher Austin, M.D., Director of the NIH Chemical Genomics Center, and Member, Editorial Board, ASSAY and Drug Development Technologies.

Forward this item to a colleague:


 
   

(Separate multiple addresses by commas)

   

(Separate multiple addresses by commas)

Be sure to take the GEN Poll

CRISPR Patent Controversy

Do you think recently released email from a former Broad Institute scientist to Jennifer Doudna will expedite a final legal decision on who owns the CRISPR patent?

More »